Login
Search
Search
0 Dates
2026
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
CPC 2026
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Looking beyond standard assessments: exploring the diagnostic potential of the MG/AVA ratio in LFLG AS
Session:
Sessão de Posters 22 - Imagem em hemodinâmica complexa e doença valvular
Speaker:
Adriana Henriques Silva
Congress:
CPC 2026
Topic:
B. Imaging
Theme:
03. Imaging
Subtheme:
03.1 Echocardiography
Session Type:
Posters Eletrónicos
FP Number:
---
Authors:
Adriana Silva; Rafael Viana; Joana Vasconcelos; Filipe Alpalhão; Kisa Congo; Isabel João; Manuel Trinca; Hélder Pereira
Abstract
<p><span style="font-size:11pt"><span style="font-family:Calibri">Introduction: Low-flow, low-gradient (LFLG) aortic stenosis (AS) is characterized by discordant grading on resting echocardiography. Recent evidence showed that mean gradient (MG)/aortic valve area (AVA) ratio can be useful in LFLG AS to confirm AS severity.</span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri">Purpose: Evaluate the diagnostic accuracy and prognostic significance of the MG/AVA ratio in our patient population with LFLG AS.</span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri">Methods: Multicenter, retrospective study. We included consecutive patients (pts) admitted for LFLG AS between 2021 and 2023. The severity of AS was determined using DSE or AVC. The optimal threshold of the MG/AVA ratio for diagnosing severe aortic stenosis was determined using Youden’s index. Prognosis included all-cause mortality and heart failure (HF) hospitalizations. </span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri">Results: A total of 91 pts were included. Baseline characteristics are summarized in Table 1. Based on echocardiography data, 65% of pts were classified as classical LFLG-AS (cLFLG-AS) and 35% as paradoxical LFLG-AS (pLFLG-AS). DSE or AVC data were available in 55% of pts, with 46% classified as having true severe AS and 54% as non-severe.</span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri">Pts with higher MG/AVA ratio (47.4 vs. 31.3, p=0.005) were more likely to have true severe AS. ROC analysis demonstrated that the ratio had moderate diagnostic accuracy (AUC 0.769). The optimal threshold for diagnosing true severe AS was 34.5 (specificity 75%, sensitivity 74%). Regarding prognosis, the optimal threshold ratio did not significantly predict all-cause mortality (p=0.466) or HF hospitalizations (p=0.278).</span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri">In a subgroup analysis of pts with cLFLG-AS, the median MG/AVA ratio was 33.9 (IQR 22.9). Pts with higher ratios (44.8 vs. 30.9, p=0.036) were more likely to have true severe AS. ROC analysis indicated moderate diagnostic accuracy (AUC 0.735), with an optimal threshold of 29.4 (specificity 67%, sensitivity 78%). Similar to the overall cohort, the ratio was not associated with mortality (p=0.712) or HF hospitalization (p=0.311).</span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri">Regarding the more specific thresholds, a ratio of 50.3 (specificity 92%, sensitivity 37%) for LFLG AS and a ratio of 47.2 (specificity 89%, sensitivity 32%) for classical LFLG AS do not demonstrate any significant prognostic impact.</span></span></p> <p><span style="font-size:11pt"><span style="font-family:Calibri">Conclusion: The MG/AVA ratio demonstrated moderate diagnostic accuracy in differentiating true severe AS in pts with LFLG AS. However, this parameter was not significantly associated with prognosis regarding all-cause mortality or HF hospitalizations. </span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site